Hypertrophic cardiomyopathy (HCM) is a complex, hereditary disease that occurs because of a thickening of the heart muscle which shrinks the blood's path through the heart, forcing the heart to work harder while pumping blood. It is often associated with sudden death in athletes and generally doesn't show symptoms prior to an episode. There is no "typical" HCM patient – it affects both the old and the young, men and women, and people of all ethnicities. Because of this, HCM is often difficult to diagnose and requires extensive treatment regimens for patients and their families.

As a recognized Center of Excellence by the Hypertrophic Cardiomyopathy Association, the University of Maryland HCM Program is only one of about 40 Centers of Excellence in the country and the only recognized center in Maryland. The University of Maryland Heart and Vascular Center delivers excellence in patient care and meets the high standards for even the most complex and complicated cases with the following:

  • Full spectrum of care from diagnosis to treatment options all in one program
  • A multidisciplinary approach for patients of all ages including pediatric and adult
  • Fully integrated cardiogenetics program that incorporates family testing and counseling
  • State-of-the-art hybrid operating room with equipment for both open and endovascular interventions to ensure the best surgical option for each patient
  • A dedicated team of specialists from cardiology, genetics, advanced imaging (echocardiogram, cardiac CT, and cardiac MRI), interventional cardiology, electrophysiology, heart failure/transplant, and cardiac surgery.
  • Groundbreaking research including two national medication studies and a cohesive patient database for translational projects

Learn more about the Hypertrophic Cardiomyopathy Program at the University of Maryland Heart and Vascular Center.

Please call 410-328-7877 or visit UMMC's Consultation and Referring Services to make a referral.

Related Content